-
Signature
-
/s/ Elizabeth Villalobos, Attorney-in-Fact for Nikesh Arora
-
Issuer symbol
-
PANW
-
Transactions as of
-
10 Oct 2024
-
Net transactions value
-
-$24,624,556
-
Form type
-
4
-
Filing time
-
15 Oct 2024, 16:30:03 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PANW |
Common Stock |
Options Exercise |
$5,398,276 |
+81,586 |
+13% |
$66.17 |
700,301 |
10 Oct 2024 |
Direct |
|
| transaction |
PANW |
Common Stock |
Sale |
$5,333,861 |
-14,552 |
-2.1% |
$366.54 |
685,749 |
10 Oct 2024 |
Direct |
F1, F2 |
| transaction |
PANW |
Common Stock |
Sale |
$8,534,786 |
-23,215 |
-3.4% |
$367.64 |
662,534 |
10 Oct 2024 |
Direct |
F1, F3 |
| transaction |
PANW |
Common Stock |
Sale |
$12,268,439 |
-33,294 |
-5% |
$368.49 |
629,240 |
10 Oct 2024 |
Direct |
F1, F4 |
| transaction |
PANW |
Common Stock |
Sale |
$3,885,746 |
-10,525 |
-1.7% |
$369.19 |
618,715 |
10 Oct 2024 |
Direct |
F1, F5 |
| holding |
PANW |
Common Stock |
|
|
|
|
|
16,005 |
10 Oct 2024 |
See footnote |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PANW |
Stock Option (right to buy) |
Options Exercise |
$0 |
-81,586 |
-3.9% |
$0.000000 |
2,000,000 |
10 Oct 2024 |
Common Stock |
81,586 |
$66.17 |
Direct |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: